• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Johns Hopkins Myositis Center

Show Search
Hide Search
  • About Myositis
    • Dermatomyositis
    • Inclusion Body Myositis
    • Juvenile Myositis
    • Polymyositis
    • Toxic Myopathies
    • Myositis Disease Education Videos
  • Our Center
    • Our Doctors
    • Our Team
    • Directions
    • Physician Referral Information
    • Preparing for an Appointment
    • In The News
  • Our Difference
    • Diagnosis of Myositis
    • Nutrition for Myositis Patients
    • Treatment of Myositis
  • Myositis Research and Clinical Trials
    • Current Research Studies
    • Recent Publications
  • Donate
    • Make a Gift
    • Peter Frampton Myositis Research Fund
Home / Educational Resources / Technologies Transforming Human Immunology

Technologies Transforming Human Immunology

February 11, 2019 By Johns Hopkins Myositis Center

Once a month, the Dean of Graduate Education at Johns Hopkins organizes a university-wide event to bring together top medical and graduate students across disciplines to discuss ways they can work together to solve an important problem in medicine.  On January 22, 2019, this Partnering Toward Discovery event entitled ““Technologies Transforming Human Immunology” was focused on Inclusion Body Myositis, and featured four 10-15 minute talks followed by a question and answer session.

First, Sahana Jayaraman, a second-year medical student in the Johns Hopkins Medical Scientist Training Program (MSTP), presents a clinical vignette of a patient with Inclusion Body Myositis (IBM) whom she saw in the Myositis Center with co-director, Thomas Lloyd, MD, PhD.  Next, Kyla Britson, a fourth-year graduate student in the Lloyd lab describes a novel xenograft mouse model she has developed to help study IBM.  Third, Ben Larman, Assistant Professor of Pathology, gives an overview of new technologies his lab is developing that are transforming human immunology. Finally, Janelle Montagne, a graduate student in the Larman lab, describes how she has developed and utilized one such novel method to identify T cells that may cause autoimmunity in IBM.

The Lloyd and Larman labs are collaborating with other members of the Myositis Center and experts in Myositis from around the world to use these novel technologies to find the cause and treatment of IBM and other forms of myositis.

Receive the Latest News from Johns Hopkins Rheumatology

Receive the Latest News from Johns Hopkins Rheumatology

Join our mailing list to receive the latest news and updates from Johns Hopkins Rheumatology.

Interested In

You have Successfully Subscribed!

Filed Under: Educational Resources

Johns Hopkins Myositis Center

USE OF THIS SITE

All information contained within the Johns Hopkins Rheumatology website is intended for educational purposes only. Physicians and other health care professionals are encouraged to consult other sources and confirm the information contained within this site. Consumers should never disregard medical advice or delay in seeking it because of something they may have read on this website.

Primary Sidebar

Footer

Johns Hopkins Rheumatology

  • Johns Hopkins Rheumatology
  • Johns Hopkins Arthritis Center
  • Johns Hopkins Lupus Center
  • Johns Hopkins Lyme Disease Research Center
  • Johns Hopkins Scleroderma Center
  • Johns Hopkins Sjögren’s Syndrome Center
  • Johns Hopkins Vasculitis Center

      

Johns Hopkins Medicine

© 2025 Johns Hopkins Myositis Center
Patient Privacy